Ascentage Pharma Group International (ASPHF) Financial Statements
$4.53OTC: ASPHFMarket Cap $1.69B
Ascentage Pharma Group International most recently reported annual revenue of $559.0M, net profit of $-1.2B, revenue has compounded at 115.6% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.